£15.0M
The Cambridge-based biotechnology company secured the Series A financing from backers including BRAIN Biotech AG and Seneca Partners.
Portfolio
1
companies
By category
- BioTech£15.0M
By location
- Cambridge£15.0M
Portfolio companies
Team
Adriaan Moelker
CEO
Adriaan brings industrial biotech, life sciences, and specialty chemicals experience from leadership roles at BRAIN Biotech, AB Enzymes, and Genencor International. He previously served as President of Image Transfer Solutions at Flint Group.